Covid-19 Pill Competing With Pfizer’s Looks for Quick Approval in Japan
TOKYO—drugmaker
Shionogi
4507 2.97%
& Co. said it plans to seek approval this month to sell its Covid-19…
Browsing Tag
4507.TO
Covid-19 Pill Developer to Spend SPAC IPO Funds on Clinical Trial, Hiring
Biopharmaceutical firm
Pardes Biosciences Inc.
plans to spend a large chunk of the funds it raised through a public offering late last month on a pill it is…
WSJ News Exclusive | Covid-19 Pill Race Heats Up as Japanese Firm Vies With Pfizer,…
A Japanese company has started human trials of the first once-a-day pill for Covid-19 patients, joining Pfizer Inc. and Merck & Co. in the race to find treatments for the…